Targeted therapy for brain cancer
Targeted therapies for brain cancer work to target specific pathways or abnormalities in brain tumor cells involved in tumor growth. We will likely combine targeted therapy with other brain cancer treatments, such as chemotherapy. This treatment is often an option for brain cancer patients who have a tumor recurrence after previous brain cancer treatments.
One targeted therapy used to treat brain tumors is the drug bevacizumab (Avastin®), which is given intravenously. This monoclonal antibody therapy works to stop the formation of new blood vessels that a brain tumor needs to grow, a process known as angiogenesis.
Managing the side effects of targeted therapy
Targeted drug therapy can cause side effects, such as low blood counts, tiredness, mouth sores, nausea, diarrhea, high blood pressure and fluid buildup (usually in the legs).
Throughout your brain cancer treatment, your care team offers various supportive care services, like nutrition therapy, naturopathic medicine, mind-body medicine and oncology rehabilitation, to keep you strong, reduce side effects and improve your quality of your life.